1. Market Research
  2. > Healthcare Market Trends
  3. > Nin Jiom Medicine Mfy (Hong Kong) Ltd in Consumer Health (Hong Kong, China)

In 2013, Nin Jiom Medicine Mfy (Hong Kong) Ltd will implement more social marketing events to enhance its publicity and positive brand image. It will continue to focus on the promotion of traditional Chinese medicine and its well-known brand, Nin Jiom Pei Pa Koa, in the forecast period.

Euromonitor International Local Company Profiles are a concise set of briefings detailing the strategic direction taken by a company. Discover key contact details, the company background and their competitive positioning through this collection of snapshot company profiles.


Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Consumer Health market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.


Table Of Contents

Nin Jiom Medicine Mfy (Hong Kong) Ltd in Consumer Health (Hong Kong, China)
NIN JIOM MEDICINE MFY (HONG KONG) LTD IN CONSUMER HEALTH (HONG KONG, CHINA)
Euromonitor International
May 2013

LIST OF CONTENTS AND TABLES

Strategic Direction
Key Facts
Summary 1 Nin Jiom Medicine Mfy (Hong Kong) Ltd: Key Facts
Company Background
Production
Competitive Positioning
Summary 2 Nin Jiom Medicine Mfy (Hong Kong) Ltd: Competitive Position 2012












View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) - Pipeline Review, H1 2016

Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) - Pipeline Review, H1 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) ...

Myocardial Fibrosis - Pipeline Review, H1 2016

Myocardial Fibrosis - Pipeline Review, H1 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Myocardial Fibrosis - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Myocardial Fibrosis - Pipeline Review, H1 2016’, provides an overview of the Myocardial Fibrosis pipeline landscape. ...

Sicca Syndrome (Sjogren) - Pipeline Review, H1 2016

Sicca Syndrome (Sjogren) - Pipeline Review, H1 2016

  • $ 42 529
  • Company report
  • June 2016
  • by Global Markets Direct

Sicca Syndrome (Sjogren) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Sicca Syndrome (Sjogren) - Pipeline Review, H1 2016’, provides an overview of the Sicca Syndrome (Sjogren) pipeline ...


ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.